River Global Investors LLP Has $3.02 Million Position in UiPath Inc. (NYSE:PATH)

River Global Investors LLP cut its stake in UiPath Inc. (NYSE:PATH) by 1.4% in the fourth quarter, HoldingsChannel.com reports. The fund owned 121,436 shares of the healthcare company’s stock after selling 1,758 shares during the period. River Global Investors LLP’s holdings in UiPath were worth $3,016,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. HighMark Wealth Management LLC bought a new stake in UiPath during the 4th quarter worth approximately $27,000. Cypress Capital Management LLC WY bought a new stake in shares of UiPath during the fourth quarter worth $29,000. GAMMA Investing LLC acquired a new stake in shares of UiPath during the fourth quarter worth $36,000. FNY Investment Advisers LLC bought a new stake in UiPath in the 4th quarter valued at $40,000. Finally, FSC Wealth Advisors LLC acquired a new position in UiPath in the 4th quarter worth $43,000. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the company’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $22.84, for a total value of $365,440.00. Following the transaction, the chief financial officer now directly owns 87,505 shares in the company, valued at $1,998,614.20. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders sold 72,000 shares of company stock valued at $1,591,360 in the last quarter. 31.03% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of analysts have recently commented on PATH shares. TD Cowen boosted their price target on UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday, March 14th. Bank of America boosted their target price on UiPath from $26.00 to $30.00 and gave the company a “buy” rating in a research note on Thursday, March 14th. Barclays raised their price target on shares of UiPath from $23.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Friday, March 15th. BMO Capital Markets boosted their price objective on shares of UiPath from $24.00 to $28.00 and gave the stock a “market perform” rating in a research report on Thursday, March 14th. Finally, Scotiabank raised their target price on shares of UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a research report on Thursday, March 14th. Nine research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, UiPath has an average rating of “Moderate Buy” and an average price target of $27.41.

UiPath Stock Up 0.9 %

Shares of PATH stock traded up $0.18 on Friday, reaching $19.48. The stock had a trading volume of 3,862,423 shares, compared to its average volume of 5,757,008. UiPath Inc. has a 12 month low of $12.38 and a 12 month high of $27.87. The firm has a market capitalization of $11.08 billion, a price-to-earnings ratio of -114.55 and a beta of 1.01. The firm’s 50-day moving average is $21.75 and its two-hundred day moving average is $21.65.

UiPath (NYSE:PATH) last released its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The firm had revenue of $405.25 million for the quarter, compared to analyst estimates of $383.32 million. On average, sell-side analysts forecast that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.